Evidence map›Paper›PMID 29657840›Full record

ArticleEFORT open reviews2018

Third-generation pure alumina and alumina matrix composites in total hip arthroplasty: What is the evidence?

Didier Hannouche, Matthieu Zingg, Hermes Miozzari, Remy Nizard, Anne Lübbeke

Open access · goldAbstract read
In one paragraph

Article in EFORT open reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Didier HannoucheDepartment of Orthopaedic Surgery and Traumatology, Geneva University Hospital, Switzerland.
Matthieu ZinggDepartment of Orthopaedic Surgery and Traumatology, Geneva University Hospital, Switzerland.
Hermes MiozzariDepartment of Orthopaedic Surgery and Traumatology, Geneva University Hospital, Switzerland.
Remy NizardDepartment of Orthopaedic Surgery, AP-HP, Hôpital Lariboisière, Paris University, Paris, France.
Anne LübbekeDepartment of Orthopaedic Surgery and Traumatology, Geneva University Hospital, Switzerland.
University Hospital of Geneva · CHHôpital Lariboisière · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wear, corrosion and periprosthetic osteolysis are important causes of failure in joint arthroplasty, especially in young patients.Ceramic bearings, developed 40 years ago, are an increasingly popular choice in hip arthroplasty. New manufacturing procedures have increased the strength and reliability of ceramic materials and reduced the risk of complications.In recent decades, ceramics made of pure alumina have continuously improved, resulting in a surgical-grade material that fulfills clinical requirements.Despite the track record of safety and long-term results, third-generation pure alumina ceramics are being replaced in clinical practice by alumina matrix composites, which are composed of alumina and zirconium.In this review, the characteristics of both materials are discussed, and the long-term results with third-generation alumina-on-alumina bearings and the associated complications are compared with those of other available ceramics. Cite this article:

Indexed as

arthroplastyceramichip

Identifiers

PMID29657840
PMCPMC5890134
OpenAlexW2783985799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.